Lihua Wang,
Senior Scientist,
Frederick National Laboratory for Cancer Research
Dr. Lihua Wang is a Senior Scientist of Laboratory of Toxicology and Pharmacology at SAIC-Frederick, Inc, National Cancer Institute. She received her Medical Degree in 1985 and PhD in Biochemistry in 1995. She has demonstrated a new paradigm in reversing of tamoxifen resistance by blocking estrogen receptor functions in breast cancer. Her research is currently focusing on pharmacodynamics of targeted anti-cancer therapeutics by using circulating tumor cells (CTCs)-based strategies for assessment of drug-induced mechanistic biomarkers. She also instructed CTC-based assays courses at NIH and Cambridge Healthtech Institute. She has published over 60 papers in peer-reviewed journals such as Nature Medicine, Cancer Cell, and Immunity.
|
|
|
Add to Calendar ▼2012-02-02 16:00:002012-02-02 17:00:00Europe/LondonNew Strategies for Analysis of CTC-Based Pharmacodynamic Biomarkers in Clinical Development of Targeted Anti-Cancer Therapeutics Circulating Tumor Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com
